Insider Transactions in Q2 2022 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 27
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,508
-42.93%
|
$1,318,740
$155.0 P/Share
|
Jun 27
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,508
+30.04%
|
$927,372
$109.45 P/Share
|
Jun 08
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,487
-24.24%
|
$1,315,485
$155.0 P/Share
|
Jun 08
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,835
+22.77%
|
$636,015
$109.45 P/Share
|
Jun 07
2022
|
Kim Sablich EVP, GM of U.S. |
SELL
Open market or private sale
|
Direct |
2,441
-1.85%
|
$366,150
$150.51 P/Share
|
Jun 06
2022
|
Kim Sablich EVP, GM of U.S. |
SELL
Open market or private sale
|
Direct |
1,388
-4.86%
|
$210,976
$152.15 P/Share
|
Jun 06
2022
|
Kim Sablich EVP, GM of U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,759
-5.8%
|
$262,091
$149.25 P/Share
|
Jun 06
2022
|
Robert Iannone EVP, Global Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,295
-3.29%
|
$192,955
$149.25 P/Share
|
Jun 06
2022
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,000
-3.07%
|
$152,000
$152.15 P/Share
|
Jun 02
2022
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
131
-2.06%
|
$19,650
$150.26 P/Share
|
Jun 02
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.28%
|
$150,000
$150.0 P/Share
|
Jun 01
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,362
-0.36%
|
$935,214
$147.62 P/Share
|
Jun 01
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.64%
|
$446,200
$46.83 P/Share
|
May 11
2022
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
722
-10.38%
|
$106,134
$147.51 P/Share
|
May 10
2022
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
161
-0.49%
|
-
|
May 10
2022
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
273
-3.78%
|
$39,312
$144.18 P/Share
|
May 09
2022
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,067
-6.44%
|
$158,983
$149.71 P/Share
|
May 09
2022
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
1,747
-8.24%
|
$258,556
$148.94 P/Share
|
May 09
2022
|
Anne O Riordan Director |
SELL
Open market or private sale
|
Direct |
466
-2.4%
|
$69,434
$149.71 P/Share
|
May 06
2022
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
296
-0.9%
|
$45,288
$153.92 P/Share
|
May 05
2022
|
Christopher J. Tovey EVP, COO & Managing Director E |
SELL
Payment of exercise price or tax liability
|
Direct |
1,096
-6.47%
|
$167,688
$153.22 P/Share
|
May 02
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
7,260
-0.41%
|
$1,139,820
$157.13 P/Share
|
May 02
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.65%
|
$446,200
$46.83 P/Share
|
Apr 05
2022
|
Renee D Gala President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,633
-4.46%
|
$264,546
$162.88 P/Share
|
Apr 04
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,772
-0.61%
|
$1,701,976
$158.17 P/Share
|
Apr 04
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.65%
|
$446,200
$46.83 P/Share
|